Assignee
NUVOX PHARMA LLC
US·8 granted patents·13 pending applications·13 citations·filing 2013–2024
Top patents by PatentIndex Score
21 records- 0194US11857627B2Fractionated radiotherapy and chemotherapy with an oxygen therapeuticNUVOX PHARMA LLC·Filed 2022·Granted Jan 2, 2024·1 cites·20 claims
- 0294US11534492B2Fractionated radiotherapy and chemotherapy with an oxygen therapeuticNUVOX PHARMA LLC·Filed 2021·Granted Dec 27, 2022·2 cites·16 claims
- 0391US2025248937A1Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereofNUVOX PHARMA LLC·Filed 2024·Application pending·0 cites
- 0488US10946097B2Fractionated radiotherapy and chemotherapy with an oxygen therapeuticNUVOX PHARMA LLC·Filed 2019·Granted Mar 16, 2021·5 cites·10 claims
- 0586US2024245773A1Fractionated radiotherapy and chemotherapy with an oxygen therapeuticNUVOX PHARMA LLC·Filed 2024·Application pending·0 cites
- 0683US10166200B2Buffered oxygen therapeuticsNUVOX PHARMA LLC·Filed 2017·Granted Jan 1, 2019·1 cites·4 claims
- 0777US10780060B2Adjusting particle size in fluorocarbon nanoemulsionsNUVOX PHARMA LLC·Filed 2016·Granted Sep 22, 2020·2 cites·6 claims
- 0877US9700523B2Buffered oxygen therapeuticNUVOX PHARMA LLC·Filed 2014·Granted Jul 11, 2017·2 cites·12 claims
- 0976US2024390290A1Iso-osmotic and near iso-osmotic oxygen therapeutic formulations and methods thereofNUVOX PHARMA LLC·Filed 2024·Application pending·0 cites
- 1073US2022401364A1Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereofNUVOX PHARMA LLC·Filed 2022·Application pending·0 cites
- 1167US11826319B2Adjusting particle size in fluorocarbon nanoemulsionsNUVOX PHARMA LLC·Filed 2020·Granted Nov 28, 2023·0 cites·7 claims
- 1267US2020163903A1Buffered Oxygen TherapeuticNUVOX PHARMA LLC·Filed 2018·Application pending·0 cites
- 1366US11304899B2Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereofNUVOX PHARMA LLC·Filed 2016·Granted Apr 19, 2022·0 cites·4 claims
- 1466US2024277627A1Novel fluorochemical cardiac resuscitationNUVOX PHARMA LLC·Filed 2023·Application pending·0 cites
- 1561US2024207199A1Fluorocarbon compositions and methods for enhancing immunotherapyNUVOX PHARMA LLC·Filed 2022·Application pending·0 cites
- 1659US2017071193A1Fluid for suspended animationNUVOX PHARMA LLC·Filed 2016·Application pending·0 cites
- 1755US2015250898A1Nanocomposites for imaging and drug deliveryNUVOX PHARMA LLC·Filed 2013·Application pending·0 cites
- 1855US2019125307A1Compositions and methods for targeted contrast agents for molecular imagingNUVOX PHARMA LLC·Filed 2017·Application pending·0 cites
- 1953US2019247526A1Microbubble Compositions, Method of Making Same, and Method Using SameNUVOX PHARMA LLC·Filed 2019·Application pending·0 cites
- 2050US2019365665A1Iso-osmotic and near iso-osmotic oxygen therapeutic formulations and methods thereofNUVOX PHARMA LLC·Filed 2018·Application pending·0 cites
- 2142US2018153824A1Treatment of acute complications of sickle cell diseaseNUVOX PHARMA LLC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →